11 min read
Monthly FDA Guidance and Regulatory News Review - June 2026
This June 2026 regulatory update focuses on advancing innovative drug development through updated guidance on...
Rare disease trials are as rewarding as they are challenging. However, with more than 350 million rare disease sufferers worldwide today, the urgency for more treatments is paramount.
At Veristat, we're passionate and work tirelessly to learn and become experts in every unique and rare disease indication we work in. To date, we've worked on more than 300 clinical projects and have prepared more than 35 regulatory submissions for rare disease therapies.
We have a wide range of rare disease clinical experience, from trial design to patient recruitment and site engagement to submission. We would love the opportunity to help you with your next rare disease trial.
To speak with our experts at the World Orphan Drug Congress, send us a meeting request in the event App or fill out the form on the right. Find out how we can help you advance your next rare disease clinical trial, program or regulatory strategy to successful outcomes.
Veristat can help you overcome the most complex challenges of conducting rare and ultra-rare disease research across a breadth of therapeutic areas - Contact us or explore more of our rare disease resources:
11 min read
Jul 7, 2026 Veristat Blog
This June 2026 regulatory update focuses on advancing innovative drug development through updated guidance on...
2 min read
Jul 2, 2026 Veristat Blog
June 22, 2026
What the FDA's prior knowledge guidance means for natural history evidence and shared datasets
On June 2,...